Adjuvant

Adjuvant Systemic Therapy After Surgery

Learn how breast cancer experts counsel their patients about the risks and benefits of adjuvant therapy in the following areas:

• Risk reduction and adjuvant chemotherapy for all types of invasive breast cancer
• Hormonal therapy for ER-positive disease
• Therapy for HER2-positive disease

Featuring Interviews with

NEW — Robert W Carlson, MD

Stanford University Medical Center 

Rowan T Chlebowski, MD, PhD

Harbor-UCLA Medical Center

NEW — Clifford Hudis, MD

Memorial Sloan-Kettering Cancer Center 

NEW — Stephen E Jones, MD 

Charles A Sammons Cancer Center 

Joyce O'Shaughnessy, MD

Baylor-Charles A Sammons Cancer Center

NEW — Peter M Ravdin, MD, PhD

The University of Texas Health Science Center 

Dennis J Slamon, MD, PhD

David Geffen School of Medicine at UCLA

Metastatic

Management of Metastatic Breast Cancer

Discover how renowned clinical research leaders explain the challenges of and chemotherapeutic options available for metastatic breast cancer.

Featuring Interviews with

NEW — Joanne L Blum, MD, PhD 

Baylor-Charles A Sammons Cancer Center 

Harold J Burstein, MD, PhD

Harvard Medical School

William J Gradishar, MD

Northwestern University Feinberg School of Medicine

NEW — Kathy D Miller, MD 

Indiana University School of Medicine

NEW — Nicholas J Robert, MD

Inova Fairfax Hospital Cancer Center

NEW — Hope S Rugo, MD 

University of California, San Francisco Comprehensive Cancer Center 

George W Sledge Jr, MD

Indiana University Medical Center